Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biontech
2
×
boston blog main
2
×
boston top stories
deals
eli lilly
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
a2 biotherapeutics
aduro biotech
agency
akili interactive labs
alicia hager
alpha-1 antitrypsin
alzheimer's disease
amag pharmaceuticals
amgen
arca biopharma
arch venture partners
arrowhead pharmaceuticals
axovant gene therapies
bacteriophage
biogen
biotech
biotech ipos
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer
cancer immunotherapy
charles rice
chinook therapeutics
clinical trials
corbus pharmaceuticals
What
bio
time
2
×
alliance
bets
bristol
buy
calls
cancer
changing
color
comes
companies
crispr
cut
date
days
deal
effective
enticed
evidence
growing
hasn’t
hours
kudos
latest
leaves
medicines
messenger
molecules
mrna
multiple
myers’s
new
notifying
october
pharmaceutical
phone
primarily
promise
proven
Language
unset
Current search:
biontech
×
time
×
" boston blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines